Search research articles
Contact Us
Filters
Showing results (351-360 of 408) with videos related to
Page
of 41
Sort By:
Cancer Cell
|
January 24, 2012
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway
Vesselina G Cooke, Valerie S LeBleu, Doruk Keskin, et al.
Journal of Medicinal Chemistry
|
July 11, 2018
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
David A Carcache, Anna Vulpetti, Joerg Kallen, et al.
Molecular Medicine (Cambridge, Mass.)
|
September 30, 2025
Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors
Jiawan Wang, Arnab Sarkar, Natalia Garcia, et al.
Science (New York, N.Y.)
|
February 17, 2007
Starch fossils and the domestication and dispersal of chili peppers (Capsicum spp. L.) in the Americas
Linda Perry, Ruth Dickau, Sonia Zarrillo, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
Shifeng Pan, Nathanael S Gray, Wenqi Gao, et al.
Cancer Discovery
|
July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)
Manav Korpal, Joshua M Korn, Xueliang Gao, et al.
Cancer Research
|
April 22, 2014
Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling
Marie Schoumacher, Kristen E Hurov, Joseph Lehár, et al.
QJM : Monthly Journal of the Association of Physicians
|
December 14, 2017
Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis
G Cooke, I Kamal, M Strengert, et al.
Biological Psychiatry
|
September 6, 2005
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial
A John Rush, Lauren B Marangell, Harold A Sackeim, et al.
Journal of Medicinal Chemistry
|
November 16, 2019
Structure-Based and Property-Driven Optimization of <i>N</i>-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors
Klemens Hoegenauer, Joerg Kallen, Eloísa Jiménez-Núñez, et al.
Page
of 41
Search research articles
Search
Showing results (351-360 of 408) with videos related to
Sort By:
Page
of 41
Cancer Cell
|
January 24, 2012
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway
Vesselina G Cooke, Valerie S LeBleu, Doruk Keskin, et al.
Journal of Medicinal Chemistry
|
July 11, 2018
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
David A Carcache, Anna Vulpetti, Joerg Kallen, et al.
Molecular Medicine (Cambridge, Mass.)
|
September 30, 2025
Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors
Jiawan Wang, Arnab Sarkar, Natalia Garcia, et al.
Science (New York, N.Y.)
|
February 17, 2007
Starch fossils and the domestication and dispersal of chili peppers (Capsicum spp. L.) in the Americas
Linda Perry, Ruth Dickau, Sonia Zarrillo, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
Shifeng Pan, Nathanael S Gray, Wenqi Gao, et al.
Cancer Discovery
|
July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)
Manav Korpal, Joshua M Korn, Xueliang Gao, et al.
Cancer Research
|
April 22, 2014
Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling
Marie Schoumacher, Kristen E Hurov, Joseph Lehár, et al.
QJM : Monthly Journal of the Association of Physicians
|
December 14, 2017
Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis
G Cooke, I Kamal, M Strengert, et al.
Biological Psychiatry
|
September 6, 2005
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial
A John Rush, Lauren B Marangell, Harold A Sackeim, et al.
Journal of Medicinal Chemistry
|
November 16, 2019
Structure-Based and Property-Driven Optimization of <i>N</i>-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors
Klemens Hoegenauer, Joerg Kallen, Eloísa Jiménez-Núñez, et al.
Page
of 41